Medication info

Pregabalin Capsule 75 mg (Pregabalin)

Prescription medicationHard capsuleOralExpired
Ingredient · strength
Pregabalin›75mg / 1 capsule
Manufacturer / importer
Korea Nelson Pharmaceutical Co., Ltd.
Appearance
Hard capsule with an upper reddish-brown and lower white shell containing a white powder that is white or light yellow.
Packaging
30 capsules/bottle, 60 capsules/bottle
Approval status
Expired

MFDS item code 201903402 · Approved 2019.05.24

This product's status changed to Expired on 2024.05.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of neuropathic pain, adjunctive treatment of epilepsy (partial seizures), treatment of fibromyalgia
Who takes it
Adults · Children
Adult dose
The total daily dose of pregabalin should be divided into 2 doses and administered orally, with or without food. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function (see section ‘5. Patients with renal impairment’). 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The starting dose is 150 mg per day. Depending on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg per day. 2) Central neuropathic pain Adults: The starting dose is 150 mg per day. Depending on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered (see section ‘4. Discontinuation of treatment’). 2. Epilepsy Adults: The starting dose is 150 mg per day. Depending on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg per day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg per day. The starting dose is 75 mg twice daily (150 mg per day), and depending on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg per day). For patients who do not experience sufficient benefit at 300 mg per day, the dose may be increased within 1 week to 225 mg twice daily (450 mg per day). Clinical studies have also been conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. Considering the dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation of treatment Based on current clinical experience, when discontinuing this medicine, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is primarily excreted unchanged by the kidneys. The clearance of this medicine is directly affected by creatinine clearance; therefore, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. *: For women, multiply the result obtained using the above equation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose according to renal function, an immediate supplemental dose should be administered after every 4 hours of hemodialysis. [Table 1]. Pregabalin dose according to renal function Creatinine clearance (CLcr), (mL/min) / Total daily dose of pregabalin a / Dosing regimen Starting dose (mg/day) / Maximum dose (mg/day) ≥60 / 150 / 600 / BID or TID ≥30 -<60 / 75 / 300 / BID or TID ≥15 -<30 / 25-50 / 150 / QD or BID <15 / 25 / 75 / QD Supplemental dose after hemodialysis / 25 / 100 / Single dose b TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = administered once daily a: The total daily dose (mg/day) should be divided as specified in the dosing regimen. b: A supplemental dose refers to an additional dose administered once. 6. Patients with hepatic impairment No dose adjustment is required in patients with hepatic impairment. 8. Older adults (65 years of age or older) Dose reduction may be necessary in older adults with impaired renal function.
Child dose
There are insufficient safety and efficacy data for children younger than 12 years and adolescent patients aged 12~17 years; therefore, use is not recommended.

Ingredients

Manufacturer
Korea Nelson Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of neuropathic pain, adjunctive treatment of epilepsy (partial seizures), treatment of fibromyalgia

  • Peripheral neuropathic pain
  • central neuropathic pain
  • epilepsy
  • secondary generalized symptoms
  • partial seizures
  • fibromyalgia
View approved original text

This medication is used for the treatment of peripheral and central neuropathic pain in adults. Additionally, it is utilized as an adjunctive therapy for patients with epilepsy experiencing partial seizures, applicable in cases accompanied by generalized symptoms or not. It also assists in alleviating symptoms in patients with fibromyalgia. It is used to improve symptoms of various neurological conditions.

How to take

Adult dose

The total daily dose of pregabalin should be divided into 2 doses and administered orally, with or without food. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function (see section ‘5. Patients with renal impairment’). 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The starting dose is 150 mg per day. Depending on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg per day. 2) Central neuropathic pain Adults: The starting dose is 150 mg per day. Depending on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered (see section ‘4. Discontinuation of treatment’). 2. Epilepsy Adults: The starting dose is 150 mg per day. Depending on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg per day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg per day. The starting dose is 75 mg twice daily (150 mg per day), and depending on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg per day). For patients who do not experience sufficient benefit at 300 mg per day, the dose may be increased within 1 week to 225 mg twice daily (450 mg per day). Clinical studies have also been conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. Considering the dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation of treatment Based on current clinical experience, when discontinuing this medicine, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is primarily excreted unchanged by the kidneys. The clearance of this medicine is directly affected by creatinine clearance; therefore, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. *: For women, multiply the result obtained using the above equation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose according to renal function, an immediate supplemental dose should be administered after every 4 hours of hemodialysis. [Table 1]. Pregabalin dose according to renal function Creatinine clearance (CLcr), (mL/min) / Total daily dose of pregabalin a / Dosing regimen Starting dose (mg/day) / Maximum dose (mg/day) ≥60 / 150 / 600 / BID or TID ≥30 -<60 / 75 / 300 / BID or TID ≥15 -<30 / 25-50 / 150 / QD or BID <15 / 25 / 75 / QD Supplemental dose after hemodialysis / 25 / 100 / Single dose b TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = administered once daily a: The total daily dose (mg/day) should be divided as specified in the dosing regimen. b: A supplemental dose refers to an additional dose administered once. 6. Patients with hepatic impairment No dose adjustment is required in patients with hepatic impairment. 8. Older adults (65 years of age or older) Dose reduction may be necessary in older adults with impaired renal function.

Child dose

There are insufficient safety and efficacy data for children younger than 12 years and adolescent patients aged 12~17 years; therefore, use is not recommended.

Precautions

This medication may increase the risk of suicidal thoughts or behaviors, so if symptoms of depression or mood changes occur while taking it, you must inform a healthcare professional immediately. Do not use this medication if you have any allergies to its ingredients or specific genetic problems such as lactose intolerance. Diabetic patients may experience weight gain after taking this medication, potentially requiring adjustments to blood sugar control medications. If severe allergic reactions such as angioedema occur, discontinue use immediately and consult with a healthcare professional. Elderly patients taking this medication may experience an increased risk of dizziness or drowsiness, leading to falls or injuries, so caution is advised. Visual disturbances or changes in sight may occur; if these symptoms appear, consult a physician. Do not abruptly discontinue this medication, as withdrawal symptoms like insomnia, headaches, or anxiety may occur; dosage should be gradually reduced under a physician's direction. There is a possibility of drug abuse or dependence, so observe mental health conditions closely, and consult with a healthcare professional before taking if there is a history of drug use. Patients with reduced kidney function may need dosage adjustments of this medication. Patients with heart conditions or congestive heart failure should use this medication cautiously. When taken with other medications that have central nervous system depressant effects, the risk of respiratory depression may increase, so caution is needed. In the early stages of pregnancy, there is a risk of congenital malformations in the fetus, so women who are pregnant or planning to become pregnant should consult before use and employ effective contraception. Breastfeeding women should consult healthcare professionals regarding the potential transmission of this medication to breast milk and its effects on the baby. When engaging in hazardous activities such as driving or operating machinery, be cautious as this medication may cause dizziness or drowsiness. In cases of overdose, severe confusion, drowsiness, and depression may occur, so adhere strictly to the prescribed dosage and contact healthcare professionals immediately if an overdose occurs. Keep out of reach of children, and be wary of transferring the medication to another container, which may lead to accidents.

Side effects

Suicidal thoughts, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, periorbital swelling, upper airway swelling, dizziness, drowsiness, loss of consciousness, confusion, mental disorders, blurred vision, changes in vision, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, melancholy, pain, sweating, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, impaired respiratory function, rhinosinusitis, neutropenia, increased appetite, decreased appetite, hypoglycemia, confusion, disorientation, irritability, euphoria, decreased libido, depersonalization, paraphilia, agitation, mood swings, emotional decline, emotional elevation, hallucinations, abnormal dreams, increased libido, panic attacks, impulsivity, numbness, ataxia, coordination abnormalities, balance disorders, amnesia, attention disorders, memory disorders, tremors, dysarthria, sensory abnormalities, sensory reduction, sedation, somnolence, cognitive impairment, nystagmus, speech disorders, myoclonus, reduced reflexes, movement abnormalities, psychomotor agitation, positional vertigo, hypersensitivity, burning sensation, action tremors, fainting, confusion, underactivity syndrome, olfactory abnormalities, loss of taste, writing difficulties, blurred vision, diplopia, indirect vision loss, visual disturbances, visual field defects, photophobia, dry eyes, conjunctival swelling, reduced vision, eye pain, eye fatigue, increased tear production, ocular irritation, mydriasis, changes in depth perception during vibration, strabismus, visual brightness, vertigo, auditory hypersensitivity, first-degree AV block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, throat tightness, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, bloating, increased salivation, gastroesophageal reflux disease, decreased oral sensation, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweat, muscle cramps, joint pain, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle spasms, throat pain, muscle stiffness, rhabdomyolysis, urination disorders, urinary incontinence, decreased urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, breast pain, nipple discharge, breast enlargement, peripheral edema, swelling, gait abnormalities, falling, feeling drunk, abnormal sensations, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, increased serum creatine phosphokinase, increased aspartate aminotransferase, increased blood sugar, decreased platelet count, decreased serum potassium, weight loss, increased serum creatinine, decreased white blood cell count, hypersensitivity, allergic reactions, headache, loss of consciousness, mental disorders, keratitis, congestive heart failure, pulmonary edema, nausea, diarrhea, tongue swelling, facial swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, fatigue, shock, anaphylactic-like symptoms, mucocutaneous syndrome, erythema multiforme, delirium, paralysis, affective disorders, drowsiness, confusional state, depression, agitation, restlessness, seizures, worsening of convulsions, gastrointestinal disorders, tinnitus, increased BUN, bloody stools

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The appropriate storage temperature is room temperature between 15 to 30 degrees Celsius, avoiding extremely hot or cold environments.

Appearance and packaging

Appearance

Hard capsule with an upper reddish-brown and lower white shell containing a white powder that is white or light yellow.

Package unit

30 capsules/bottle, 60 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.